Publications

2013

Tumor versus Stromal Cells in Culture-Survival of the Fittest?

Talasila KM, Brekka N, Mangseth K, Stieber D, Evensen L, Rosland GV, Torsvik A, Wagner M, Niclou SP, Mahesparan R, Vintermyr OK, Bjerkvig R, Nigro JM, Miletic H. 2013 Dec. PLoS One.8(12):e81183.

Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF.

Podergajs N, Brekka N, Radlwimmer B, Herold-Mende C, Talasila Krishna M, Tiemann K, Rajcevic U, Lah Tamara T, Bjerkvig R, Miletic H. 2013 Dec. Radiol Oncol.47(4):330-337. Epub 2013 Oct 8.

Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.

Baginska J, Viry E, Berchem G, Poli A, Noman MZ, van Moer K, Medves S, Zimmer J, Oudin A, Niclou SP, Bleackley RC, Goping IS, Chouaib S, Janji B. 2013 Oct. Proc Natl Acad Sci U S A.110(43):17450-5. Epub 2013 Oct 7.

Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids.

Primon M, Huszthy PC, Motaln H, Talasila KM, Torkar A, Bjerkvig R, Lah Turnsek T. 2013 Oct. Exp Cell Res.19(17):2637-48. Epub 2013 Aug 19.

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

Johansson M, Oudin A, Tiemann K, Bernard A, Golebiewska A, Keunen O, Fack F, Stieber D, Wang B, Hedman H, Niclou SP. 2013 Sep. Neuro Oncol.15(9):1200-11. Epub 2013 May 30.

Drug-domain interaction networks in myocardial infarction.

Wang H, Zheng H, Azuaje F, Zhao XM. 2013 Sep. IEEE Trans Nanobioscience.12(3):182-8. Epub 2013 Aug 19.

Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model.

Petersen K, Rajcevic U, Abdul Rahim SA, Jonassen I, Kalland K-H, Jimenez CR, Bjerkvig R, Niclou SP. 2013 Jul. PLoS ONE.8(7):e68288.

In vivo animal models for studying brain metastasis: value and limitations.

Daphu I, Sundstrom T, Horn S, Huszthy PC, Niclou SP, Sakariassen PO, Immervoll H, Miletic H, Bjerkvig R, Thorsen F. 2013 Jun. Clin Exp Metastasis.30(5):695-710. Epub 2013 Jan 16.

Combined effect of tissue stabilization and protein extraction methods on phosphoprotein analysis.

Kofanova OA, Fack F, Niclou SP, Betsou F. 2013 Jun. Biopreserv Biobank.11(3):161-165.

Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α -KG.

Navis AC, Niclou SP, Fack F, Stieber D, van Lith S, Verrijp K, Wright A, Stauber J, Tops B, Otte-Holler I. 2013 May. Acta Neuropathol Commun.1:18.

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.

Golebiewska A, Bougnaud S, Stieber D, Brons NH, Vallar L, Hertel F, Klink B, Schrock E, Bjerkvig R, Niclou SP. 2013 May. Brain.136(Pt 5):1462-75. Epub 2013 Mar 4.

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.

Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PO, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mork SJ, Enger PO, Bjerkvig R, Miletic H. 2013 May. Acta Neuropathol.125(5):683-98. Epub 2013 Feb 22.

Automated Tracking of Nanoparticle-labeled Melanoma Cells Improves the Predictive Power of a Brain Metastasis Model.

Sundstrom T, Daphu I, Wendelbo I, Hodneland E, Lundervold A, Immervoll H, Skaftnesmo KO, Babic M, Jendelova P, Sykova E, Lund-Johansen M, Bjerkvig R, Thorsen F. 2013 Apr. Cancer Res.73(8):2445-2456. Epub 2013 Feb 19.

Mesenchymal stem cell signaling in cancer progression.

Torsvik A, Bjerkvig R. 2013 Apr. Cancer Treat Rev.39(2):180-8. Epub 2012 Apr 9.

Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease.

Azuaje F, Zhang L, Jeanty C, Puhl SL, Rodius S, Wagner DR. 2013 Apr. BMC Med Genomics.6(1):13.

Selectivity of LC-MS/MS analysis: Implication for proteomics experiments.

Gallien S, Duriez E, Demeure K, Domon B. 2013 Apr. J Proteomics.81:148-58. Epub 2012 Nov 14.

A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.

Klink B, Miletic H, Stieber D, Huszthy PC, Valenzuela JA, Balss J, Wang J, Schubert M, Sakariassen PO, Sundstrom T, Torsvik A, Aarhus M, Mahesparan R, von Deimling A, Kaderali L, Niclou SP, Schrock E, Bjerkvig R, Nigro JM. 2013 Mar. PLoS One.8(3):e59773. Epub 2013 Mar 19.

Drug interaction networks: An introduction to translational and clinical applications.

Azuaje F. 2013 Mar. Cardiovasc Res.97(4):631-41. Epub 2012 Sep 12.

Animal models for low-grade gliomas. In Diffuse Low-Grade Gliomas in Adults . 1st ed. (Book Chapter)

Bjerkvig R, Bougnaud S, Niclou SP. 2013 Mar. Duffau H, ed. Berlin: Springer, 2013. p.165-175. ISBN 978-1-4471-2212-8.

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R. 2013 Mar. Neuro Oncol.15(3):269-78. Epub 2012 Dec 20.

Tumor vasculature: the Achilles' heel of cancer?

Johannessen TC, Wagner M, Straume O, Bjerkvig R, Eikesdal HP. 2013 Jan. Expert Opin Ther Targets.17(1):7-20. Epub 2012 Nov 2.